ECM
HAE icon

Element Capital Management’s Haemonetics HAE Stock Holding History

Element Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,545
Closed -$2.74M – 95
2023
Q3 		$2.74M Sell
30,545
-3,263
-10% -$291K 0.24% 116
2023
Q2 		$2.88M Buy
+33,808
New +$2.86M 0.19% 135
2018
Q4 		– Sell
-1,899
Closed -$218K – 747
2018
Q3 		$218K Sell
1,899
-1,501
-44% -$155K ﹤0.01% 740
2018
Q2 		$305K Buy
+3,400
New +$287K 0.01% 542

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Element Capital Management's HAE Position: Q4 2023 in Review

Element Capital Management sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 30,545 shares — an estimated $2.74M sold.

Element Capital Management first reported a position in HAE in Q2 2018 and held it in 4 quarters. The position peaked at $2.88M in Q2 2023. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

  • Element Capital Management reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 30,545 Haemonetics shares in Q4 2023, an estimated $2.74M.
  • Element Capital Management first reported a position in Haemonetics in Q2 2018 and held it in 4 quarters.
  • Element Capital Management's Haemonetics position peaked at $2.88M in Q2 2023.
  • 295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.